|
|
|
|
|
SCIENTIFIC PROGRAMME GECOP
|
Simultaneous Translation into English-Spanish-English
will be provided in sessions with these requirements.
 |
Final Program |
List
of Pósters
|
|
|
|
thursday, 3 october 2013
|
|
08:30 – 10:30 h.
Room A
GECOP
Sesion |
Oral Communications
&
Videos 01GE |
|
12:00 – 13:30 h.
Room B |
Treatment of peritoneal carcinomatosis
of colorectal cancer. Present and future.
| Chairs |
Dr. Pedro Barrios Sánchez
Dr. Juan Torres Melero |
| Speakers |
Oncologist
point of view
Dr. Enrique Aranda Aguilar
Surgeon point of view
Dr. Jesús Esquivel
Ongoing Studies: Prodige 7 and Prodige 15
Dr. Oliver Glehen
Patient ultraselection
Dr. Pedro Barrios Sánchez |
|
|
13:30 – 14:00 h.
Room B
|
GECOP Assembly |
|
14:00 – 15:00 h. |
Lunch |
|
15:00 – 16:30 h.
Room A
|
Oral Communications 02GE |
|
16:30 – 16:45 h. |
Coffee-Break / Posters Session
List
of Posters
|
|
17:15 – 19:00 h.
Room B
|
Peritoneal metastases from gastric
cancer
| Chairs |
Dra. Gloria Ortega Pérez
Dr. Paul H. Sugarbaker |
| Speakers |
Peritoneal
Cytology in Gastric Cancer and Its Implications for decision making.
Dr. Santiago González-Moreno
Therapeutic options in gastric cancer with carcinomatosis.
Dra. Ana Ruiz Casado
French results of the treatment from gastric carcinomatosis with
HIPEC.
Dr. Olivier Glehen
Gastric Cancer with Carcinomatosis: Bidirectional chemotherapy and
cytoreductive surgery with HIPEC.
Dr. Luis González Bayón |
|
|
friday, 4 october 2013
|
|
09:00–10:00 h.
Room B |
Oral Communications 03GE |
|
10:00–11:30 h.
Room B |
Ovarian Peritoneal Carcinomatosis
| Chairs |
Dr. Francisco Cristobal Muñoz Casares
Dr. Pedro Antonio Cascales Campos |
| Speakers |
HIPEC after
cytoreduction of peritoneal carcinomatosis in primary and recurrent
ovarian cancer. Favorable clinical scenarios.
Dr. Marcello Deraco
Other methods of intraperitoneal chemotherapy in primary and
recurrent ovarian.peritoneal carcinomatosis.
Dr.
Francisco C. Muñoz Casares
New alternatives in the systemic treatment of advanced ovarian
cancer.
Dr. Andres Poveda |
|
|
11:30 – 12:00 h. |
Coffee-Break / Posters Session
List
of Posters
|
|
12:00–13:30 h.
Room B
|
Peritoneal mesothelioma and
pseudomyxoma
| Chairs |
Dr. Alberto Gómez Portilla
Dr. Bruno Camps Vilata |
|
Speakers |
Advances in
molecular profiling and personalized treatment of peritoneal
mesothelioma
Dr. Marcello Deraco
Treatment of peritoneal pseudomyxoma
Dr. Richard H. Alexander
Our experience in the treatment of mesothelioma and peritoneal
pseudomyxoma with CRS + HIPEC.
Evaluation of the Spanish national registry
Dr. Pedro Barrios Sánchez |
|
|
13:30 –14:30 h.
Room B |
Oral Communication 04GE |
|
13:30 –14:30 h.
Room D |
Oral Communication 05GE |
|
14:30 – 15:30 h. |
Lunch |
15:30 – 16:00 h.
Room B
|
Conference
Optimizing HIPEC by Preclinical Pharmacologic
Studies
Prof. Paul H. Sugarbaker
Washington Cancer Institute. MedStar Washington Hospital
Center. Washington, USA |
|
16:00 – 17:30 h.
Room B |
Peritoneal carcinomatosis.
Miscellaneous
| Chairs |
Dr. Pedro
Bretcha
Dr. José del Pino Monzón |
| Ponencias |
Peritoneum/plasmatic membrane. Do we really know it?
Dra. María Eva Baró Salvador
Pharmacological aspects of hyperthermic intraperitoneal chemotherapy:
pharmacokinetic considerations
Dra. Belén Valenzuela Jiménez
Pharmacological aspects of hyperthermic intraperitoneal chemotherapy:
pharmacodynamic considerations
Dr. Juan José Pérez Ruixo
Spanish National Register of carcinomatosis.
Dra. Isabel Ramos
How to organize a peritoneal cancer surgical unit.
Dr. Rafael Morales.
Prognostic value of circulating tumor cells (and its phenotyping) in
patients with peritoneal carcinomatosis of colorectal cancer
candidates to CRS + HIPEC.
Dr. Juan Torres Melero |
|
|
17:30 – 17:45 h. |
Coffee-Break |
Top |
|
|
|
